DiNome v. Cordis Corporation

CourtDistrict Court, S.D. New York
DecidedAugust 21, 2024
Docket1:23-cv-11173
StatusUnknown

This text of DiNome v. Cordis Corporation (DiNome v. Cordis Corporation) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
DiNome v. Cordis Corporation, (S.D.N.Y. 2024).

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK MICHELLE DINOME, Plaintiff, – against – OPINION & ORDER 23-CV-11173 (ER) CORDIS US CORP., CORDIS CORPORATION, DENNIS WHALEN, and DAVID HUNT, Defendants. RAMOS, D.J.: Michele DiNome brings this action against Cordis US Corporation and Cordis Corporation (collectively, “Cordis”), and Cordis executives Dennis Whalen and David Hunt (collectively, “Defendants), for allegedly subjecting her to a hostile work environment, discriminating against her on the basis of age and sex, retaliating against her after she reported Cordis’ illegal and unsafe activity, and failing to provide her with reasonable accommodations for her disability. DiNome alleges violations of Title VII of the Civil Rights Act of 1964 (“Title VII”), the Age Discrimination in Employment Act of 1967 (“ADEA”), the New York Labor Law § 740 (“NYLL”), the Americans with Disabilities Act (“ADA”), the New York State Human Rights Law (“NYSHRL”), and the New York City Human Rights Law (“NYCHRL”). Before the court is Defendants’ motion to partially dismiss the Amended Complaint with prejudice for failure to state a claim pursuant to Fed. R. Civ. P. 12(b)(6). Defendants are moving to dismiss only the NYLL retaliation claim and the ADA, NYSHRL, and NYCHRL failure to accommodate claims. For the reasons set forth below, the motion is GRANTED. I. BACKGROUND A. Statement of the Facts 1. The Parties DiNome is an experienced clinical sales professional who previously worked for, among other medical device companies, Philips-IGT-D (“Philips”), before she was hired as an associate manager at Cordis. ¶¶ 13, 16, 19.1 Cordis is a global leader in the development and manufacture of medical devices for diagnostics and interventional procedures to treat coronary and peripheral vascular diseases. ¶ 14; see also Doc. 19-1 at 3. Whalen is and was a supervisor at Cordis during DiNome’s employment. ¶ 11. Hunt is a former vice president of sales for Cordis who worked during DiNome’s employment. ¶¶ 12, 30. 2. Employment with Cordis On June 1, 2022, DiNome was hired by defendant Whalen and started at Cordis the same day as another woman named Caroline Casey (“Casey”). ¶ 19. In her Amended Complaint, DiNome alleges another associate, Jon Ketz (“Ketz”), trained her on only one case before directing her to begin “in-servicing” medical devices without supervision.2 ¶ 24. She expressed her discomfort in using the devices without adequate training to Cordis’ senior management and Whalen several times throughout the summer of 2022.3 ¶ 22. In addition, according to DiNome, Cordis required fellows4 to work on five to seven cases with Cordis representatives before being permitted to use Cordis’ medical devices without the participation of a Cordis representative. ¶ 24. However, DiNome alleges this protocol was being monitored only “loosely” by Casey.5 Id. On one

1 Unless otherwise noted, citations to “¶__” refer to the Amended Complaint, Doc. 18. 2 DiNome does not explain what “in-servicing” means. 3 DiNome does not provide any dates or additional facts explaining who she spoke to regarding her concerns of Cordis’ purportedly unsafe training protocols. 4 DiNome does not describe what fellows are, or their responsibilities. 5 DiNome does not specify whether she reported her concerns regarding Cordis’ protocol for training new fellows to Cordis management. occasion, she recalled a device was not deploying correctly during a procedure on a patient. Id. The malfunction required the application of manual pressure to the patient’s groin. Id. When DiNome asked to follow the patient to the postoperative unit, where patients are monitored after a procedure, she was warned by Casey that doing so would draw negative attention to the Cordis device. Id. DiNome suggests this was evidence Cordis condoned unsafe patient practices. Id. 3. Dr. Krishnan’s Lab DiNome further alleges that between August 4 and 18, 2022, Dr. Krishnan, a doctor at Mount Sinai Hospital, suggested that he would use one of Cordis’ medical devices, Mynx Control, 6 in return for a $50,000 donation to his educational grant/symposium. ¶ 23. DiNome was uncomfortable with this suggestion and reported Dr. Krishnan’s request to Cordis senior management and Whalen. Id. “It appeared [to DiNome] that Cordis… was not familiar” with Dr. Krishnan’s history of requiring medical device companies donate to his grant/symposium in exchange for using their products.7 ¶ 25. On August 12, 2022, Dr. Krishnan asked DiNome and Casey to train fellows on how to use the Mynx Control device at his lab. Id. When they arrived, another doctor, Dr. Srinivas Dukkpati, told DiNome that Dr. Krishnan specifically instructed him not to use the Mynx Control device. Id. DiNome then disclosed “certain experiences she had with Dr. Krishnan” and the complaints she made about him at her prior employer, Philips, to Casey. Id. It appeared to DiNome that Casey was also unfamiliar with Dr. Krishnan’s requirement that medical device companies donate to his grant/symposium. Id. DiNome alleges she was concerned that Dr. Krishnan was directing doctors at Mount Sinai to avoid using the Mynx Control device either to put pressure on Cordis to participate in his kickback scheme or to retaliate against her for

6 DiNome does not further explain what the Mynx Control device is. 7 When she left Philips, DiNome reported in writing unethical conduct she witnessed, including Dr. Krishnan’s kickback scheme which required medical device companies donate to his grant/symposium to have their products used in his lab. ¶ 25. having reported him and the kickback scheme he was running at Philips. Id. After the lab visit, Casey was approached by another doctor, Dr. Mark Miller, who asked her who DiNome was.8 ¶ 26. Casey provided him with information about DiNome’s role and revealed that DiNome was concerned about Dr. Krishnan retaliating against her for having made complaints at Philips regarding his alleged kickback scheme. Id. At some point thereafter, Whalen approached DiNome yelling about how the [Krishnan] account was worth $1 million, and asked her to stay out of the catheterization lab and concentrate on interventional radiology (“IR”) and operating room (“OR”). Id. DiNome alleges Whalen was angry with her for “not going along with the kickback scheme and being so vocal about it both with [Philips] and Cordis.”9 Id. 4. The Retaliation After reporting her concerns about the inadequate training she purportedly received and Dr. Krishnan’s suggestion that Cordis donate to his grant/symposium, DiNome alleges that her team thereafter stopped supporting her when “it became clear Cordis was the party retaliating against her” for the complaints she made at Philips. ¶¶ 26–27. Specifically, Ketz initially refused to train her on one of Cordis’ new medical devices when a client expressed interest in using it. ¶ 27. DiNome also alleges that Whalen pressured other female employees to suggest that she leave the job. ¶ 28. For example, Amanda Nixon, who had previously been helpful to her, was “clearly” asked to be rude to her when she told DiNome, “[w]ell you’d make $175,000 a year as a physician’s assistant.”10 Id. During the week of September 25, 2022, DiNome expressed interest in applying for a new role within the company. ¶ 28. In a conversation with DiNome discussing the

8 The Amended Complaint does not offer any additional information about who Dr. Mark Miller is and what relationship, if any, he has with the relevant parties in this case. 9 DiNome never alleges that she reported Dr. Krishnan’s kickback scheme to Cordis management or Whalen. 10 The Amended Complaint does not provide any additional details about the context of this statement.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

McDonnell Douglas Corp. v. Green
411 U.S. 792 (Supreme Court, 1973)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Lisa Strickland v. Saint Lukes Health System
377 F. App'x 569 (Eighth Circuit, 2010)
DiFolco v. MSNBC Cable L.L.C.
622 F.3d 104 (Second Circuit, 2010)
Williams v. Citigroup Inc.
659 F.3d 208 (Second Circuit, 2011)
Louis Carter v. Dutchess Community College
735 F.2d 8 (Second Circuit, 1984)
Walker v. Schult
717 F.3d 119 (Second Circuit, 2013)
Shomo v. City of New York
579 F.3d 176 (Second Circuit, 2009)
O'BRIEN v. National Property Analysts Partners
719 F. Supp. 222 (S.D. New York, 1989)
Reilly v. Revlon, Inc.
620 F. Supp. 2d 524 (S.D. New York, 2009)
Johnson v. Boardman Petroleum, Inc.
923 F. Supp. 1563 (S.D. Georgia, 1996)
Borrero v. American Express Bank Ltd.
533 F. Supp. 2d 429 (S.D. New York, 2008)
Kwan v. The Andalex Group LLC
737 F.3d 834 (Second Circuit, 2013)
Dooley v. JetBlue Airways Corp.
636 F. App'x 16 (Second Circuit, 2015)
Ray v. Weit
708 F. App'x 719 (Second Circuit, 2017)
Webb-Weber v. Community Action for Human Services, Inc.
15 N.E.3d 1172 (New York Court of Appeals, 2014)

Cite This Page — Counsel Stack

Bluebook (online)
DiNome v. Cordis Corporation, Counsel Stack Legal Research, https://law.counselstack.com/opinion/dinome-v-cordis-corporation-nysd-2024.